Market News (Page 51) - TendieTensor

Market News Page 51 of 287 • 7,173 articles

HEYTEA Partners with POP MART’s Twinkle Twinkle for First Global Simultaneous Launch

GlobeNewswire Inc. • Na

HEYTEA Partners with POP MART’s Twinkle Twinkle for First Global Simultaneous Launch

12/29/2025 11:57 AM • HEYTEA and POP MART launched their first globally synchronized co-branded campaign featuring the Twinkle Twinkle IP across December 22, spanning over 100 stores worldwide including China, Hong Kong, Macao, and international markets in the US, UK, and Canada. The collaboration includes custom character designs, co-branded drinks, themed merchandise, and pop-up activations, reflecting HEYTEA's strategy of using localized, culturally relevant partnerships to build international presence while maintaining global brand coherence.

BMO - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
PMRTY - POP MART's Twinkle Twinkle IP is being leveraged in a major global co-branded campaign with HEYTEA, demonstrating strong IP value and market appeal. The collaboration spans multiple regions and generates significant social media attention, indicating successful IP monetization and brand partnership opportunities.

#HEYTEA #POP MART #Twinkle Twinkle #co-branded campaign #global expansion #tea beverages #seasonal collaboration #international markets #product innovation #pop-up activation

Societe Generale: Information regarding executed transactions within the framework of a share buy-back programme

GlobeNewswire Inc. • Na

Societe Generale: Information regarding executed transactions within the framework of a share buy-back programme

12/29/2025 11:46 AM • As of 26 December 2025, Societe Generale has repurchased 1.3% of its capital and completed 61.4% of its previously announced EUR 1 billion share buy-back programme. During the period of 22-26 December 2025, the bank purchased 716,800 shares across multiple markets at a daily weighted average price of €67.77 per share.

BNKD - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
SCGLY - The company is actively executing its announced share buy-back programme, having completed over 61% of the EUR 1 billion commitment. Share buy-backs are generally viewed positively as they can support stock prices, reduce share count, and signal management confidence in the company's valuation and financial position.

#share buy-back #capital repurchase #EUR 1 billion #shareholder returns #equity transactions

Melexis: update over het aandeleninkoopprogramma

GlobeNewswire Inc. • Na

Melexis: update over het aandeleninkoopprogramma

12/29/2025 11:45 AM • Melexis announced the purchase of 11,600 shares on Euronext Brussels between December 22-24, 2025, at an average price of €56.64 per share, totaling €656,972. Under the current buy-back program for up to 850,000 shares, Melexis has now acquired 40,200 shares, bringing total treasury shares to 871,691 when combined with previous programs.

BULZ - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
MLXSY - The share buy-back is a routine capital allocation activity that demonstrates confidence in the company's valuation and financial position. However, it is neither inherently positive nor negative as it represents a neutral corporate action with no material business impact disclosed.

#share buy-back #treasury shares #Euronext Brussels #capital allocation #shareholder returns

Melexis: update on the share buy-back program

GlobeNewswire Inc. • Na

Melexis: update on the share buy-back program

12/29/2025 11:45 AM • Melexis completed the purchase of 11,600 shares between December 22-26, 2025, as part of its announced share buy-back program. The company acquired shares at an average price of €56.64, bringing total treasury shares held to 871,691 shares under current and previous buy-back programs.

BNKU - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
MLXSY - The share buy-back is a routine capital allocation activity that demonstrates confidence in the company's valuation and commitment to shareholder returns. However, it is a neutral event as it neither indicates significant business growth nor operational challenges. The consistent execution of the announced program at stable prices reflects normal corporate operations.

#share buy-back #treasury shares #Euronext Brussels #capital allocation #shareholder returns

New career development Book from Palmetto Publishing titled HIRED! Gives Job Seekers a Proven, Step-by-Step Playbook to Land the Job They Want.

GlobeNewswire Inc. • Victoria Feldman And Tatiana Topiol Kimron

New career development Book from Palmetto Publishing titled HIRED! Gives Job Seekers a Proven, Step-by-Step Playbook to Land the Job They Want.

12/29/2025 11:00 AM • Career coaches Victoria Feldman and Tatiana Topiol Kimron have published 'HIRED!', a job search guide based on their experience at major tech companies. The book provides practical strategies to help job seekers stand out in competitive markets, prepare for interviews, and secure positions that align with their goals.

AMZN - Mentioned as a past employer of co-author Victoria Feldman, demonstrating her experience in talent development at major tech companies. No positive or negative business implications are discussed.

#career development #job search #hiring strategies #career coaching #tech industry #interview preparation

FLY Investors Have Opportunity to Lead Firefly Aerospace Inc. Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • Schall Law Firm

FLY Investors Have Opportunity to Lead Firefly Aerospace Inc. Securities Fraud Lawsuit with the Schall Law Firm

12/29/2025 10:50 AM • The Schall Law Firm has filed a class action lawsuit against Firefly Aerospace Inc. (NASDAQ: FLY) for securities fraud, alleging the company made false and misleading statements during its August 2025 IPO. The complaint claims Firefly overstated growth potential and commercial viability of its Spacecraft Solutions business and Alpha rocket program. Investors who purchased securities during the class period are encouraged to join the lawsuit by January 12, 2026.

FLY - The company is the subject of a securities fraud lawsuit alleging material misstatements about its business growth potential and commercial viability. These allegations indicate serious corporate governance and disclosure violations that resulted in investor losses.

#securities fraud #class action lawsuit #IPO #false statements #Firefly Aerospace #shareholder rights

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • Schall Law Firm

SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm

12/29/2025 10:45 AM • The Schall Law Firm has filed a securities fraud class action lawsuit against Skye Bioscience, Inc. (NASDAQ: SKYE) for allegedly making false and misleading statements about its drug candidate nimacimab, overstating its commercial and clinical prospects. Investors who purchased securities between November 4, 2024 and October 3, 2025 are encouraged to join the lawsuit by January 16, 2026.

SKYE - The company is accused of making false and misleading statements about its drug candidate's effectiveness and overstating commercial and clinical prospects, resulting in investor losses when the truth was revealed to the market.

#securities fraud #class action lawsuit #Skye Bioscience #nimacimab #false statements #shareholder rights #investor losses

FRMI INVESTIGATION ALERT: Investigation Launched into Fermi Inc., RGRD Law Encourages Investors and Potential Witnesses to Contact Law Firm

GlobeNewswire Inc. • Robbins Geller Rudman & Dowd Llp

FRMI INVESTIGATION ALERT: Investigation Launched into Fermi Inc., RGRD Law Encourages Investors and Potential Witnesses to Contact Law Firm

12/29/2025 10:40 AM • Robbins Geller Rudman & Dowd LLP has launched an investigation into Fermi Inc. for potential securities law violations related to false or misleading statements. The investigation was triggered after Fermi's major tenant terminated a $150 million construction funding agreement in December 2025, causing the stock to plummet 33% from its $21 IPO price to $10.09.

BERZ - Proposed a modular approach to AI agents, focusing on specialized, discrete task performance
FRMI - Major tenant terminated a critical $150 million construction funding agreement, stock fell 33% below IPO price, and the company is under investigation for potential securities law violations involving false or misleading statements to investors.

#securities fraud investigation #IPO #false statements #material information #stock price decline #tenant termination #construction funding

GlobeNewswire Inc. • Na

Form 8.3 - Empiric Student Property Plc

12/29/2025 09:58 AM • Rathbones Group Plc has disclosed a 2.77% interest in Empiric Student Property Plc, comprising 18,456,582 ordinary shares. The disclosure was made following a sale of 49,960 shares at 76.52p per share on 24/12/2025, as required under Rule 8.3 of the Takeover Code.

STRC - Shares declined for fourth straight session to lowest level in over a year
EPRCY - Subject of a standard disclosure filing indicating a significant shareholder position. The disclosure itself is procedural and does not convey positive or negative sentiment about the company's prospects.

#stake disclosure #Takeover Code #Rule 8.3 #share sale #relevant securities #public opening position disclosure

Portnoy Law Firm Announces Class Action on Behalf of DeFi Technologies, Inc. Investors

GlobeNewswire Inc. • Portnoy Law Firm

Portnoy Law Firm Announces Class Action on Behalf of DeFi Technologies, Inc. Investors

12/29/2025 09:51 AM • The Portnoy Law Firm has announced a class action lawsuit on behalf of DeFi Technologies investors who purchased securities between May 12, 2025 and November 14, 2025. The lawsuit alleges that DeFi Technologies made false and misleading statements regarding delays in executing its DeFi arbitrage strategy, understated competition from digital asset treasury companies, and failed to meet its 2025 revenue guidance. Investors have until January 30, 2026 to file a lead plaintiff motion.

STRD - Shares declined for fourth straight session to lowest level in over a year
DEFT - The company is the subject of a securities fraud class action lawsuit alleging material misstatements about its core DeFi arbitrage strategy, competitive position, and inability to meet revenue guidance. These allegations indicate serious operational and disclosure failures that resulted in investor losses.

#class action lawsuit #DeFi Technologies #securities fraud #false statements #revenue guidance #DeFi arbitrage strategy #investor losses

KMX Investors Have Opportunity to Lead CarMax, Inc. Securities Fraud Lawsuit with the Schall Law Firm

GlobeNewswire Inc. • The Schall Law Firm

KMX Investors Have Opportunity to Lead CarMax, Inc. Securities Fraud Lawsuit with the Schall Law Firm

12/29/2025 09:50 AM • The Schall Law Firm is seeking investors who purchased CarMax securities between June 20, 2025 and September 24, 2025 to join a class action lawsuit alleging securities fraud. CarMax allegedly made false and misleading statements by overstating growth prospects, with actual growth driven by customer speculation about vehicle tariffs rather than genuine business performance.

STRF - Shares declined for fourth straight session to lowest level in over a year
KMX - The company is accused of making false and misleading statements about growth prospects, with actual growth artificially inflated by tariff speculation rather than genuine business fundamentals. This resulted in investor losses and triggered a securities fraud lawsuit.

#securities fraud #class action lawsuit #CarMax #false statements #investor losses #tariff speculation

Portnoy Law Firm Announces Class Action on Behalf of BitDeer Technologies Group Investors

GlobeNewswire Inc. • Portnoy Law Firm

Portnoy Law Firm Announces Class Action on Behalf of BitDeer Technologies Group Investors

12/29/2025 09:49 AM • The Portnoy Law Firm has announced a class action lawsuit on behalf of BitDeer Technologies Group investors who purchased securities between June 6, 2024 and November 10, 2025. The lawsuit was triggered after BitDeer reported significantly worse-than-expected Q3 2025 earnings (EPS of -$1.28 vs. consensus of -$0.22) and disclosed major delays in its next-generation Seal 04 ASIC chip development. The stock fell 14.9% on the news.

STRK - Shares declined for fourth straight session to lowest level in over a year
BTDR - Company significantly missed earnings expectations (EPS of -$1.28 vs. -$0.22 consensus), disclosed major delays in critical next-generation chip development, and experienced a 14.9% stock price decline, triggering a class action lawsuit for investor losses.

#class action lawsuit #BitDeer Technologies #missed earnings #ASIC chip delay #stock decline #investor losses

Portnoy Law Firm Announces Class Action on Behalf of Avantor, Inc. Investors

GlobeNewswire Inc. • Portnoy Law Firm

Portnoy Law Firm Announces Class Action on Behalf of Avantor, Inc. Investors

12/29/2025 09:45 AM • Avantor, Inc. faces a class action lawsuit alleging that company executives failed to disclose weakening competitive positioning and increased competitive intensity affecting its Laboratory Solutions business. The company cut guidance multiple times in 2025 after reporting weak organic sales growth. Stock prices fell significantly following each earnings announcement (16%, 15%, and 23% declines), with the third quarter results revealing that actual performance was worse than management's recent projections.

AVTR - The company is facing a class action lawsuit for allegedly failing to disclose weakening competitive positioning. Multiple guidance cuts throughout 2025, significant stock price declines following earnings announcements, and management admissions of increased competitive intensity and reduced customer volumes indicate serious operational and financial deterioration.

#class action lawsuit #securities fraud #competitive intensity #guidance cuts #Laboratory Solutions #organic sales decline #stock price decline #disclosure failure

Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio

GlobeNewswire Inc. • Na

Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio

12/29/2025 09:00 AM • Nutriband Inc. announced the sale of a 90% stake in its subsidiary Pocono Pharmaceutical to EarthVision Bio for $5 million USD, with Nutriband shareholders retaining 10% ownership. The company plans to use proceeds to develop AVERSA Fentanyl, an abuse-deterrent opioid patch with potential annual US sales of $80-200 million. EarthVision Bio is developing sustainable product alternatives founded by Intel co-founder Dr. Gordon Moore and ex-Chevron Europe chairman Dr. Hans Franke.

NTRB - Company is raising capital ($5M) to fund development of its lead product AVERSA Fentanyl with significant market potential ($80-200M annual sales). The divestment of non-core subsidiary allows focus on higher-value pharmaceutical development. Retention of 10% stake in EarthVision Bio provides upside participation.

#asset sale #subsidiary divestment #abuse-deterrent fentanyl #transdermal pharmaceutical #sustainable products #opioid innovation

NDBT Elects Casey Plummer to Board of Directors

GlobeNewswire Inc. • Na

NDBT Elects Casey Plummer to Board of Directors

12/29/2025 09:00 AM • North Dallas Bank and Trust Co. (NDBT) announced the election of Casey Plummer to its Board of Directors, effective January 1, 2026. Plummer is the founder and principal of Plummer Development Company and serves as Treasurer for The Human Impact, a nonprofit serving the homeless population in Dallas. NDBT leadership praised Plummer's commitment to community service and business excellence.

NODB - The appointment of an accomplished business leader and community servant to the board demonstrates strong corporate governance and commitment to community engagement. The endorsement from CEO Larry Miller highlights leadership quality and the bank's values-driven culture.

#board appointment #community banking #real estate development #nonprofit partnership #Dallas #corporate governance

The AI Data Center Boom Goes Public: From “Neoclouds” to Power, Cooling, and the Grid

GlobeNewswire Inc. • Microcaps.Com

The AI Data Center Boom Goes Public: From “Neoclouds” to Power, Cooling, and the Grid

12/29/2025 09:00 AM • As AI infrastructure spending accelerates, public markets are increasingly valuing companies across the data center ecosystem—from GPU suppliers to cooling systems and asset-light platforms. Companies exposed to AI infrastructure trade at 20-30x revenue multiples, significantly higher than S&P 500 averages, reflecting investor confidence in long-term growth despite capital intensity and execution risks. The sector is evolving beyond the GPU race toward infrastructure readiness, with power, cooling, and interconnection becoming as critical as chips themselves.

NVDA - Positioned as a central player in AI infrastructure with prominent role in powering large-scale AI compute clusters; benefits from accelerating demand for GPUs as foundational to AI data center buildout.

#AI data centers #GPU infrastructure #valuation multiples #capital intensity #neoclouds #liquid cooling #power delivery #asset-light models #infrastructure investment

Verizon to report earnings January 30, 2026

GlobeNewswire Inc. • Na

Verizon to report earnings January 30, 2026

12/29/2025 09:00 AM • Verizon Communications Inc. announced it will report fourth-quarter 2025 earnings on January 30, 2026, with a webcast presentation at 8:00 a.m. ET. Materials will be available on the company's Investor Relations website starting at 6:30 a.m. ET.

VZ - The article is a factual announcement of an upcoming earnings report date and webcast. It contains no forward-looking statements, performance metrics, or information that would indicate positive or negative business developments. It is purely procedural in nature.

#earnings report #fourth-quarter 2025 #investor relations #webcast #financial results

Spain's Economic Resilience: Strong Growth, Low Inflation, And Structural Reforms Post-Pandemic

Benzinga • Mighty Wisdom

Spain's Economic Resilience: Strong Growth, Low Inflation, And Structural Reforms Post-Pandemic

12/29/2025 08:38 AM • Spain's economy has emerged as one of Europe's strongest performers with projected 2025 GDP growth of 2.5%, significantly above eurozone average. Key drivers include controlled inflation near 2.3%, employment reaching historical highs with unemployment at ~10%, strong tourism sector contributing €249 billion to GDP, and rapid renewable energy expansion now accounting for over 50% of electricity generation. High-value sectors including technology, professional services, and green infrastructure are fueling diversified growth.

WDGF - Article notes defense firms are experiencing increased demand linked to higher European defense spending, supporting growth prospects.

#Spain economy #GDP growth #inflation control #labor market reform #tourism #renewable energy #technology sector #eurozone #employment

REE Automotive Ties Up With BorgWarner Unit To Power Next-Gen EV Drive Systems

Benzinga • Lekha Gupta

REE Automotive Ties Up With BorgWarner Unit To Power Next-Gen EV Drive Systems

12/29/2025 08:32 AM • REE Automotive signed a strategic memorandum of understanding with Cascadia Motion (BorgWarner subsidiary) to co-develop next-generation electric drive units combining Cascadia Motion's iM-125 motor-inverter with REEcorner technology. The collaboration includes a royalty-based arrangement and targets OEM electrification initiatives. REE shares rose 4.64% in premarket trading.

CSCO - Jumped 4.5% after beating analyst expectations and providing positive guidance
REE - Strategic partnership with major automotive supplier BorgWarner expands REE's addressable market and validates its REEcorner technology. The deal includes royalty-based revenue potential and access to OEM customers. Stock price increased 4.64% in premarket trading, reflecting positive market reception.

#electric drive unit #REEcorner technology #software-defined vehicle #OEM electrification #strategic partnership #EV technology

Why One Investor Sold $6 Million of the MSCI China ETF Amid a Nearly 30% Run

The Motley Fool • Jonathan Ponciano

Why One Investor Sold $6 Million of the MSCI China ETF Amid a Nearly 30% Run

12/29/2025 08:30 AM • Hong Kong-based Fosun International completely exited its $5.84 million position in the iShares MSCI China ETF (MCHI) during Q3, selling 106,000 shares. The exit comes after the ETF surged nearly 30% year-to-date, reflecting a broad recovery in Chinese equities. The move reflects risk management and portfolio rebalancing rather than bearish sentiment on China, as investors trim exposure after strong gains to reallocate capital to better risk-reward opportunities.

MSTR - Shares declined for fourth straight session to lowest level in over a year
MCHI - The ETF experienced strong performance (30% YTD gain), but the investor's exit reflects tactical rebalancing and risk management rather than negative outlook. The article frames this as disciplined portfolio architecture following a sharp rebound, not a bearish signal on the fund itself.

#China ETF #portfolio exit #risk management #Chinese equities #institutional investor #profit-taking #rebalancing

Kratos Receives Approximately $30 Million in Air Defense and C5ISR System National-Security-Related Hardware Production Contracts

GlobeNewswire Inc. • Na

Kratos Receives Approximately $30 Million in Air Defense and C5ISR System National-Security-Related Hardware Production Contracts

12/29/2025 08:00 AM • Kratos Defense & Security Solutions announced it has received approximately $30 million in contracts for air defense and C5ISR system military-grade custom hardware production. The company will perform work in secure manufacturing facilities, leveraging its expertise in missile, radar, counter-UAS, and other complex defense systems.

AAPL - Part of tech sector experiencing investment shifts, but no specific negative indicators mentioned
KTOS - The company secured $30 million in new defense contracts, demonstrating strong customer confidence and continued demand for its military-grade hardware production capabilities. Leadership statements emphasize the company's competitive advantages in delivering mission-critical systems on time and at scale, indicating healthy business momentum and market position.

#defense contracts #military hardware #air defense systems #C5ISR #national security #manufacturing #hypersonic systems #counter-UAS

Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor

GlobeNewswire Inc. • Na

Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor

12/29/2025 08:00 AM • Praxis Precision Medicines received FDA Breakthrough Therapy Designation for ulixacaltamide, a T-type calcium channel inhibitor for essential tremor treatment, based on positive Phase 3 Essential3 program results. The company plans to submit a New Drug Application (NDA) in early 2026 following a successful pre-NDA meeting with the FDA.

PRAX - The company received FDA Breakthrough Therapy Designation, which accelerates development and regulatory review. Positive Phase 3 trial results and successful pre-NDA alignment with FDA support faster advancement toward commercialization. The designation addresses a significant unmet medical need in a large patient population (7 million in the US), representing substantial commercial opportunity.

#Breakthrough Therapy Designation #ulixacaltamide #essential tremor #FDA approval #NDA submission #T-type calcium channels #Phase 3 clinical trial

Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum

GlobeNewswire Inc. • Not Specified

Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum

12/29/2025 08:00 AM • Reviva Pharmaceuticals Holdings, Inc. announced that its Founder, President, and CEO Laxminarayan Bhat will present at the Sachs 9th Annual Neuroscience Innovation Forum on January 11, 2026, in San Francisco. The late-stage biopharmaceutical company is developing therapies for CNS, inflammatory, and cardiometabolic diseases, with two main drug candidates: brilaroxazine (RP5063) and RP1208.

KLXY - Rising for five consecutive sessions, reflecting growing confidence in luxury brands
RVPH - The article is primarily a conference presentation announcement with standard corporate disclosure. While the company mentions ongoing FDA interactions and potential NDA submission timelines for brilaroxazine, the main content is promotional in nature. The regulatory update referenced suggests FDA requested additional Phase 3 data, which is neither particularly positive nor negative, representing a typical development pathway adjustment.

#Reviva Pharmaceuticals #brilaroxazine #RP5063 #RP1208 #CNS diseases #schizophrenia #FDA #NDA submission #Phase 3 trial #biopharmaceutical

BiomX Announces $3.0 Million Private Placement

GlobeNewswire Inc. • Biomx Inc.

BiomX Announces $3.0 Million Private Placement

12/29/2025 08:00 AM • BiomX Inc. announced a private placement financing of approximately $3.0 million gross proceeds through the issuance of Series Y Convertible Preferred Stock and warrants. The company plans to use net proceeds to assess opportunities for its bacteriophage programs, including BX011 for diabetic foot infections, and for general corporate purposes while evaluating strategic alternatives.

DECK - Included in top luxury index, indicating potential for growth in high-end market
PHGE - The company secured $3.0 million in funding, which is positive for liquidity. However, the relatively modest funding amount, ongoing evaluation of strategic alternatives, and discontinuation of the BX004 CF trial (mentioned in supplementary content) suggest financial constraints and development challenges. The neutral sentiment reflects both the capital raise and underlying operational uncertainties.

#private placement #convertible preferred stock #warrants #phage therapy #BX011 #financing #strategic alternatives

Theriva™ Biologics anuncia el asesoramiento científico favorable de la Agencia Europea de Medicamentos (EMA) sobre el diseño de un ensayo de fase III de VCN-01 en el adenocarcinoma ductal pancreático (ACDP) metastásico

GlobeNewswire Inc. • Theriva Biologics, Inc.

Theriva™ Biologics anuncia el asesoramiento científico favorable de la Agencia Europea de Medicamentos (EMA) sobre el diseño de un ensayo de fase III de VCN-01 en el adenocarcinoma ductal pancreático (ACDP) metastásico

12/29/2025 08:00 AM • Theriva Biologics received favorable scientific advice from the European Medicines Agency (EMA) on the design of a Phase 3 clinical trial for VCN-01 in combination with gemcitabine/nab-paclitaxel for treating metastatic pancreatic ductal adenocarcinoma (PDAC). The EMA approved the proposed trial design, sample size, and adaptive design elements. The company plans to meet with the FDA in H1 2026 for a multinational Phase 3 trial and has cash runway through Q1 2027.

LRLCY - Part of top luxury index holdings, positioned to benefit from premium consumer trends
TOVX - The company received favorable regulatory guidance from the EMA on its lead candidate VCN-01, with approval of the Phase 3 trial design including sample size and dosing regimen. The EMA's recognition of improved survival outcomes with multiple VCN-01 doses and acceptance of repeated dosing cycles strengthens the development pathway. Planned FDA meeting in H1 2026 and adequate cash runway through Q1 2027 support near-term progress on pivotal trials.

#VCN-01 #pancreatic cancer #Phase 3 trial #EMA approval #gemcitabine/nab-paclitaxel #oncolytic adenovirus #retinoblastoma #clinical development